Matthew Davis

Matthew Davis

Företagsledare/Principal på AQUESTIVE THERAPEUTICS, INC.

Förmögenhet: 511 000 $ per 2026-08-31

Health Technology
Consumer Services
Consumer Non-Durables

Profil

Dr. Matthew W.
Davis
, MD, is a Chief Development Officer at Aquestive Therapeutics, Inc. and an Adjunct Associate Professor at Temple University (Pennsylvania).
Dr. Davis was previously employed as a Chief Operating & Medical Officer by Tiziana Life Sciences Ltd. (United Kingdom), a Chief Operating & Medical Officer by Tiziana Life Sciences Ltd. (Bermuda), a SVP-Research & Development Branded Pharmaceuticals by Endo International Plc, a Vice President-Branded Products & Medical Affairs by URL Pharma, Inc., a Head-Medical Affairs by Dermik Laboratories, Inc., a Head-Clinical Development & Medical Affairs by Dr. Reddy's Laboratories, Inc., a Head-Medical Affairs & Pharmacovigilance by Endo Pharmaceuticals, Inc., a Chief Medical Officer by Lupin, Inc., and a Chief Medical Officer by Neuvivo, Inc. He received his undergraduate degree from Temple University School of Pharmacy and a doctorate degree from Drexel University College of Medicine.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-03-09 100 000 ( 0,08 % ) 511 000 $ 2026-08-31

Aktiva positioner av Matthew Davis

FöretagPositionStart
AQUESTIVE THERAPEUTICS, INC. Företagsledare/Principal 2025-11-04
Företagsledare/Principal -

Tidigare kända positioner av Matthew Davis

FöretagPositionSlut
TIZIANA LIFE SCIENCES LTD Verksamhetschef 2024-07-01
Teknisk/Vetenskaplig/F&U Direktör -
Teknisk/Vetenskaplig/F&U Direktör -
Verksamhetschef -
ENDO INTERNATIONAL PLC Företagsledare/Principal -
Se detaljerna i Matthew Daviss erfarenhet

Matthew Daviss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

65

Första gradens relationer

13

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag13

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Non-Durables

Health Technology

Health Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Matthew Davis